Related Experiment Video
Updated: Feb 5, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with
A Schimmenti1, E Brunetti1,2, E Seminari2
1Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Unità di Malattie Infettive e Tropicali ed Epatologia, Università di Pavia, Pavia, Italy.
Abstract:
Antimicrobial resistance in Gram-negative bacteria, particularly Enterobacteriaceae, has become a leading cause of morbidity and mortality and a serious public health concern. Gram-negative bacteria carrying extended-spectrum beta-lactamase (ESBL) enzymes now represent a significant proportion of all bacteria isolated from different countries worldwide. Furthermore, the increasing number of isolates carrying carbapenemases in recent years includes multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria. Here, we describe what, to our knowledge, is the first case of a patient with a prosthetic joint infection from carbapenemase-resistant Klebsiella pneumoniae (CRKP) successfully treated with ceftazidime-avibactam in Italy.
Insights
Antimicrobial resistance is a major health threat. This study reports the first successful treatment of a prosthetic joint infection caused by carbapenemase-resistant Klebsiella pneumoniae using ceftazidime-avibactam.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Antimicrobial resistance in Gram-negative bacteria, especially Enterobacteriaceae, is a significant global health issue.
- Extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing bacteria are increasingly prevalent, leading to multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) infections.
- Prosthetic joint infections (PJIs) pose a serious challenge due to limited treatment options for resistant pathogens.
Observation:
- A patient in Italy presented with a prosthetic joint infection.
- The infection was caused by carbapenemase-resistant Klebsiella pneumoniae (CRKP), a highly resistant Gram-negative bacterium.
- Standard treatment options were likely limited due to the resistance profile.
Findings:
- The patient with CRKP prosthetic joint infection was successfully treated with ceftazidime-avibactam.
- This represents a novel therapeutic approach for this challenging infection.
- Ceftazidime-avibactam demonstrated efficacy against a carbapenemase-resistant Gram-negative pathogen in a PJI setting.
Implications:
- Ceftazidime-avibactam offers a potential treatment option for prosthetic joint infections caused by carbapenemase-resistant Gram-negative bacteria.
- This case highlights the importance of novel antimicrobial agents in combating rising antimicrobial resistance.
- Further research is warranted to evaluate the broader efficacy and safety of ceftazidime-avibactam in similar complex infections.
Related Concept Videos
Structural Joints: Synovial Joints
Structural Joints: Fibrous Joints
Suture
All the bones of the skull, except for the mandible, are joined to each other by a fibrous joint called a suture. The fibrous connective tissue found at a suture strongly unites the adjacent skull bones and thus helps to protect the brain and form the face. In...
Structural Joints: Cartilaginous Joints
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary...
Joints
Structural joint classifications are based on the material that makes up the joint as well as whether or not the joint contains a space between the bones. Joints are structurally classified as fibrous, cartilaginous, or synovial.
Fibrous Joints Are Immovable
The bones of a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

